Compare Tempus AI (TEM) vs Teradyne, Inc. (TER) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Tempus AI vs Teradyne, Inc. — how do they compare? Tempus AI trades at $60.4 (market cap $11.13B), while Teradyne, Inc. trades at $379.74 (market cap $59.99B). The key difference: Teradyne, Inc. is far larger — about 5.4× Tempus AI's market cap, and Teradyne, Inc. pays a 0.14% dividend while Tempus AI pays none. Which is the better fit depends on your goals.
| TEM | TER | |
|---|---|---|
Market Cap | $11.13B | $59.99B |
Sector | Broad Market / Factor | Technology |
52-Week High | $103.25 | $483.84 |
52-Week Low | $41.55 | $112.24 |
Enterprise Value | $11.75B | $59.73B |
Dividend Yield | — | 0.14% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Tempus AI (TEM) trades at $64.29, down 0.51% on the day, with a bullish technical signal from moving averages and RSI near oversold levels. The company reported a net loss of $245.03M in 2025 despite revenue of $1.27B, but recent quarterly EPS beats and FDA clearance for an AI-enabled ECG product (Business Wire, 2026-08-24) highlight growth potential in precision medicine. Analyst consensus is strongly bullish with a $69.20 price target.
Outlook: TEM's AI-driven healthcare platform positions it for long-term growth amid industry shifts toward personalized medicine, though persistent losses and high P/B of 25.01 pose valuation risks. Near-term catalysts include continued execution on recent contracts and pipeline developments, but investors face volatility from cash burn and competitive pressures.
Teradyne (TER) trades at $372.06, up 4.21% in the last session, with a bullish technical signal and strong institutional interest. The stock shows robust fundamentals, including a 59.24% gross margin and consistent earnings beats, with Q3 2026 EPS expected at $2.03. Recent news highlights AI-driven demand for UltraFLEXplus systems, positioning TER for growth in semiconductor testing.
Outlook is positive with a $474.78 analyst price target implying 28% upside, supported by AI and data center expansion. Risks include reliance on tech cycles and competitive pressures from KLA and Cohu. Cash flow trends show improvement, with net cash flow projected to turn positive in 2026.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Tempus AI
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →About Teradyne, Inc.
Teradyne provides testing equipment, including automated test equipment for semiconductors, system testing for hard disk drives, circuit boards, and electronics systems and wireless testing for devices. The firm entered the industrial automation market in 2015, into which it sells collaborative and autonomous robots for factory applications. Teradyne serves numerous end markets and geographies directly and indirectly with its products, but its most significant exposure is to semiconductor testing, which made up 71% of 2021 sales. Teradyne serves vertically integrated, fabless, and foundry chipmakers with its equipment.
Read more on TER →
